Neuroprotection in progressive brain disorders

Ruth Djaldetti1, Nirit Lev, Eldad Melamed

  • 1Department of Neurology, Rabin Medical Center (Beilinson Campus), Petah Tiqva, Israel. yhaimi@bezeqint.net

Insights

Researchers are exploring neuroprotective agents to combat cell death in progressive neurodegenerative disorders. While clinical evidence is currently limited, ongoing research into novel compounds and technologies shows promise for future treatments.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Progressive neurodegenerative disorders involve shared cell death mechanisms.
  • Multiple contributing factors are implicated in these complex diseases.

Purpose of the Study:

  • To investigate neuroprotective agents for slowing or preventing cell loss.
  • To review current experimental and clinical research on neuroprotection.

Main Methods:

  • Review of experimental animal and clinical studies.
  • Investigation of caspase inhibitors, antioxidants, glutamate antagonists, anti-inflammatory agents, and trophic factors.

Main Results:

  • Limited clinical evidence currently exists for direct neuroprotective effects.
  • Significant research efforts are focused on novel technologies and compounds.

Conclusions:

  • Further research is needed to establish effective neuroprotective therapies.
  • Novel approaches are under active investigation for neurodegenerative diseases.

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
54.0K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Neuroplasticity01:01

Neuroplasticity

Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
2.0K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K